A Study on the Correlation Between Tear Iron Levels and the Severity of Dry Eye Disease.
Condition(s) studied
Investigational drug(s) / intervention(s)
Diagnostic tear fluid collection and ocular surface evaluation: This is an observational study; no therapeutic intervention is administered. All participants undergo a single, standardized study visit that includes: Tear Fluid Collection: Tear samples are collected using sterile Schirmer test strips (without anesthesia) placed in the lower conjunctival sac for 5 minutes. Comprehensive Ocular Surface Evaluation: Symptom Assessment: Completion of the Ocular Surface Disease Index (OSDI) questionnaire. Clinical Tests: Measurement of fluorescein tear film breakup time (FBUT), corneal fluorescein staining (CFS) scoring, and Schirmer I test. The collected tear samples are subsequently analyzed for iron concentration. All procedures are diagnostic and evaluative in nature.
Study summary
This study aims to see if the amount of iron in tears is linked to how severe dry eye disease is. We hope this can lead to a new way to help diagnose and understand dry eye. This is an observational study. We will compare tear samples from people with dry eye to samples from people with healthy eyes. We will measure the iron content in the tears and see if it correlates with standard dry eye test results and symptom scores.
Eligibility
Primary outcome measure(s)
- Correlation between tear fluid iron concentration and dry eye symptom severity — baseline
The strength of association between the concentration of iron (in μg/mL) in tear fluid collected via Schirmer strips and the total score on the Ocular Surface Disease Index (OSDI) questionnaire.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Changzheng Hospital | Shanghai | China | Recruiting |
More Shanghai Changzheng Hospital trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07363824 on ClinicalTrials.gov ↗ ← All trials in China